Found: 8
Select item for more details and to access through your institution.
Biopharmazeutika durch flanzliche roduktion n eschlossenen Systemen.
- Published in:
- TechnoPharm, 2015, v. 5, n. 5, p. 256
- By:
- Publication type:
- Article
Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1383123
- By:
- Publication type:
- Article
Moss-Derived Human Recombinant GAA Provides an Optimized Enzyme Uptake in Differentiated Human Muscle Cells of Pompe Disease.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 7, p. 2642, doi. 10.3390/ijms21072642
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics, and safety of moss‐aGalactosidase A in patients with Fabry disease.
- Published in:
- Journal of Inherited Metabolic Disease, 2019, v. 42, n. 3, p. 527, doi. 10.1002/jimd.12052
- By:
- Publication type:
- Article
Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry mice.
- Published in:
- Journal of Inherited Metabolic Disease, 2016, v. 39, n. 2, p. 293, doi. 10.1007/s10545-015-9886-9
- By:
- Publication type:
- Article
Comparison of efficacy between subcutaneous and intravenous application of moss‐aGal in the mouse model of Fabry disease.
- Published in:
- Journal of Inherited Metabolic Disease Reports, 2023, v. 64, n. 6, p. 460, doi. 10.1002/jmd2.12393
- By:
- Publication type:
- Article
Uptake of moss‐derived human recombinant GAA in Gaa<sup>−/−</sup> mice.
- Published in:
- Journal of Inherited Metabolic Disease Reports, 2021, v. 59, n. 1, p. 81, doi. 10.1002/jmd2.12203
- By:
- Publication type:
- Article
Production of biologically active recombinant human factor H in Physcomitrella.
- Published in:
- Plant Biotechnology Journal, 2011, v. 9, n. 3, p. 373, doi. 10.1111/j.1467-7652.2010.00552.x
- By:
- Publication type:
- Article